On 23 August 2011 OBJ Limited announced that the US Patent Office had allowed the company’s Dermaportation Patent to proceed to “allowance”. The announcement then went on to say that after OBJ had paid all the necessary fees that the full patent would be granted within 3 months.
At the time I posted this article discussing what the patent meant and the implications it may have on the signing of any future agreements. With any bio-tech stock there are many pieces to the puzzle, however the granting of this patent represents a significant step towards commercialisation in my opinion. Put simply no global pharmaceutical company would risk millions of dollars to manufacture a new product if it was not protected and could therefore be easily copied by their competitors.
This morning a very well respected poster on Hot Copper provided a link to a site that provides information on Patent Applications. The document on the link states:
Patent 8019412 Issued on September 13, 2011
Inventor: Edwards, Jeffrey D.
Assignee: International Scientific Pty Ltd
For those of you who are not aware International Scientific is a wholly owned subsidiary of OBJ Limited.
Based on this news I anticipate an announcement will be made to the market in the next few days (perhaps even today). At this stage I think the announcement will only cover the granting of the Patent and will not provide any additional information on potential partners, however, as I said above this is an important step for the company.
As always please do your own research, nothing I say is advice or a recommendation to make any investment or trade. You should consult a licenced financial advisor prior to making any investment decision.
No comments:
Post a Comment